MACROGENICS INC (MGNX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 70M 140M 210M Q4 '12: 63.8M Q1 '13: 53.9M Q2 '13: 48.8M Q3 '13: 52.9M Q4 '13: 58M Q1 '14: 62.2M Q2 '14: 59.1M Q3 '14: 57.2M Q4 '14: 47.8M Q1 '15: 104.4M Q2 '15: 101.9M Q3 '15: 98.2M Q4 '15: 100.9M Q1 '16: 32.4M Q2 '16: 106.4M Q3 '16: 95M Q4 '16: 91.9M Q1 '17: 91.1M Q2 '17: 12.1M Q3 '17: 10.5M Q4 '17: 157.7M Q1 '18: 160.4M Q2 '18: 177.6M Q3 '18: 196.7M Q4 '18: 60.1M Q1 '19: 65.1M Q2 '19: 56.8M Q3 '19: 54.8M Q4 '19: 64.2M Q1 '20: 68.2M Q2 '20: 77.9M Q3 '20: 77.4M Q4 '20: 104.9M Q1 '21: 108.1M Q2 '21: 118.6M Q3 '21: 116M Q4 '21: 77.4M Q1 '22: 71.7M Q2 '22: 66.9M Q3 '22: 93M Q4 '22: 151.9M Q1 '23: 165.3M Q2 '23: 152.5M Q3 '23: 121.1M Q4 '23: 58.7M Q1 '24: 43.4M Q2 '24: 41M Q3 '24: 141.3M Q4 '24: 150M Q1 '25: 154.1M Q2 '25: 150.1M Q3 '25: 112.3M Q4 '25: 134.1M Q1 '26: 141.7M Q2 '26: 167.7M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Gross Profit TTM

0 60M 120M 180M Q4 '20: 104.9M Q1 '21: 108.1M Q2 '21: 118.5M Q3 '21: 114.3M Q4 '21: 74.8M Q1 '22: 69M Q2 '22: 64.1M Q3 '22: 88.8M Q4 '22: 148.6M Q1 '23: 161.9M Q2 '23: 149M Q3 '23: 120.6M Q4 '23: 58.1M Q1 '24: 42.6M Q2 '24: 40.3M Q3 '24: 140.6M Q4 '24: 149.1M Q1 '25: 153.5M Q2 '25: 149.7M Q3 '25: 112M Q4 '25: 134.1M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-240M -160M -80M 0 80M 160M 240M Q4 '13: 366K Q1 '14: 589.7K Q2 '14: -11.4M Q3 '14: -22.5M Q4 '14: -38.3M Q1 '15: 9.9M Q2 '15: 895K Q3 '15: -10.6M Q4 '15: -20.2M Q1 '16: -95.9M Q2 '16: -34.6M Q3 '16: -53.4M Q4 '16: -60M Q1 '17: -67.6M Q2 '17: -148.9M Q3 '17: -162.3M Q4 '17: -22.1M Q1 '18: -34.1M Q2 '18: -37.3M Q3 '18: -24.6M Q4 '18: -171.2M Q1 '19: -168.6M Q2 '19: -177.3M Q3 '19: -180.2M Q4 '19: -177.2M Q1 '20: -175M Q2 '20: -169.4M Q3 '20: -167.5M Q4 '20: -131.1M Q1 '21: -136.9M Q2 '21: -129.9M Q3 '21: -146.7M Q4 '21: -202.8M Q1 '22: -218.1M Q2 '22: -219.7M Q3 '22: -191.6M Q4 '22: -121.4M Q1 '23: -93.2M Q2 '23: -96.4M Q3 '23: -106.9M Q4 '23: -168.2M Q1 '24: -183.6M Q2 '24: -196.8M Q3 '24: -107.1M Q4 '24: -110.6M Q1 '25: -99.5M Q2 '25: -84.5M Q3 '25: -120M Q4 '25: -72.8M Q1 '26: -63.7M Q2 '26: -34.3M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Net Income TTM

-240M -160M -80M 0 80M 160M 240M Q4 '12: 8.4M Q1 '13: 675.6K Q2 '13: -3.2M Q3 '13: 839.1K Q4 '13: -260.9K Q1 '14: -3K Q2 '14: -12M Q3 '14: -22.5M Q4 '14: -38.3M Q1 '15: 9.9M Q2 '15: 807K Q3 '15: -10.7M Q4 '15: -20.1M Q1 '16: -95.6M Q2 '16: -33.8M Q3 '16: -52.2M Q4 '16: -58.5M Q1 '17: -65.8M Q2 '17: -146.9M Q3 '17: -160.1M Q4 '17: -19.6M Q1 '18: -31.5M Q2 '18: -34.1M Q3 '18: -21.1M Q4 '18: -171.5M Q1 '19: -166.9M Q2 '19: -155.5M Q3 '19: -166.1M Q4 '19: -151.8M Q1 '20: -151.5M Q2 '20: -166.6M Q3 '20: -158M Q4 '20: -129.7M Q1 '21: -136.3M Q2 '21: -129.3M Q3 '21: -146.2M Q4 '21: -202.1M Q1 '22: -217.3M Q2 '22: -218.7M Q3 '22: -190.6M Q4 '22: -119.8M Q1 '23: -91.3M Q2 '23: 7.4M Q3 '23: 49.8M Q4 '23: -9.1M Q1 '24: -23.2M Q2 '24: -136.4M Q3 '24: -97.6M Q4 '24: -67M Q1 '25: -55.8M Q2 '25: -36.4M Q3 '25: -75.9M Q4 '25: -74.6M Q1 '26: -70.4M Q2 '26: -14.6M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue TTM

0 1.5M 3M 4.5M Q4 '20: 0 Q1 '21: 17K Q2 '21: 39K Q3 '21: 1.7M Q4 '21: 2.7M Q1 '22: 2.7M Q2 '22: 2.8M Q3 '22: 4.2M Q4 '22: 3.4M Q1 '23: 3.4M Q2 '23: 3.5M Q3 '23: 572K Q4 '23: 619K Q1 '24: 776K Q2 '24: 694K Q3 '24: 777K Q4 '24: 847K Q1 '25: 577K Q2 '25: 401K Q3 '25: 233K Q4 '25: 0 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Operating Cash Flow TTM

-180M -120M -60M 0 60M 120M 180M Q4 '13: -14.2M Q1 '14: -4.4M Q2 '14: 1.4M Q3 '14: -13.8M Q4 '14: -32.8M Q1 '15: 4.9M Q2 '15: -16.4M Q3 '15: -9.7M Q4 '15: -13.7M Q1 '16: -89.2M Q2 '16: -96.9M Q3 '16: -39.5M Q4 '16: -43.7M Q1 '17: -47.1M Q2 '17: -44.6M Q3 '17: -125.8M Q4 '17: 14.4M Q1 '18: 18.4M Q2 '18: -8.5M Q3 '18: -14.2M Q4 '18: -153.2M Q1 '19: -151.9M Q2 '19: -143M Q3 '19: -123.5M Q4 '19: -134.3M Q1 '20: -148.4M Q2 '20: -136.1M Q3 '20: -144.4M Q4 '20: -111.9M Q1 '21: -96.8M Q2 '21: -105.9M Q3 '21: -95.1M Q4 '21: -143.8M Q1 '22: -172.5M Q2 '22: -176M Q3 '22: -170.6M Q4 '22: -87M Q1 '23: -42.1M Q2 '23: 5M Q3 '23: -20.8M Q4 '23: -78.2M Q1 '24: -111M Q2 '24: -153.4M Q3 '24: -58M Q4 '24: -68.4M Q1 '25: -69.6M Q2 '25: -72.1M Q3 '25: -162.5M Q4 '25: -81M Q1 '26: -70M Q2 '26: -63.7M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Free Cash Flow TTM

-210M -140M -70M 0 70M 140M 210M Q4 '13: -17.1M Q1 '14: -7.4M Q2 '14: -2M Q3 '14: -16.6M Q4 '14: -36.3M Q1 '15: 826K Q2 '15: -22.5M Q3 '15: -17.7M Q4 '15: -22.9M Q1 '16: -100.2M Q2 '16: -110.7M Q3 '16: -52.6M Q4 '16: -55.1M Q1 '17: -57.1M Q2 '17: -56.5M Q3 '17: -145.5M Q4 '17: -15M Q1 '18: -24M Q2 '18: -49.2M Q3 '18: -49.2M Q4 '18: -178.2M Q1 '19: -164M Q2 '19: -150.2M Q3 '19: -127.2M Q4 '19: -138.6M Q1 '20: -152.3M Q2 '20: -140M Q3 '20: -148M Q4 '20: -117.8M Q1 '21: -102.1M Q2 '21: -112.7M Q3 '21: -103.4M Q4 '21: -150M Q1 '22: -179.5M Q2 '22: -181.9M Q3 '22: -175.2M Q4 '22: -90.6M Q1 '23: -44.7M Q2 '23: 3.1M Q3 '23: -22.4M Q4 '23: -80M Q1 '24: -113.9M Q2 '24: -157M Q3 '24: -61.7M Q4 '24: -72.1M Q1 '25: -72.4M Q2 '25: -74.6M Q3 '25: -164.8M Q4 '25: -83M Q1 '26: -71.7M Q2 '26: -65.5M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q3 '12: 21.5M Q1 '13: 1.1M Q2 '13: 1.2M Q3 '13: 21.2M Q1 '14: 26.3M Q2 '14: 27.7M Q3 '14: 27.8M Q1 '15: 31.7M Q2 '15: 30.1M Q3 '15: 33.3M Q1 '16: 34.5M Q2 '16: 36M Q3 '16: 34.8M Q1 '17: 35M Q2 '17: 35.8M Q3 '17: 36.8M Q1 '18: 36.9M Q2 '18: 42.2M Q2 '20: 50M Q3 '20: 54.5M Q1 '21: 57.2M Q2 '21: 60.1M Q3 '21: 61.2M Q1 '22: 61.3M Q2 '22: 61.4M Q3 '22: 61.5M Q1 '23: 61.8M Q2 '23: 62.3M Q3 '23: 62.2M Q1 '24: 62.3M Q2 '24: 62.7M Q3 '24: 62.9M Q1 '25: 63M Q2 '25: 63.1M Q3 '25: 63.3M Q1 '26: 63.4M Q2 '26: 63.6M Q1 '13 Q3 '14 Q2 '16 Q1 '18 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q4 '12: -1.92 Q1 '13: -4.85 Q2 '13: -5.09 Q3 '14: -0.84 Q4 '14: -1.39 Q1 '15: 0.15 Q2 '15: -0.12 Q3 '15: -0.44 Q4 '15: -0.58 Q1 '16: -2.88 Q2 '16: -1.05 Q3 '16: -1.56 Q4 '16: -1.73 Q1 '17: -1.93 Q2 '17: -4.19 Q3 '17: -4.50 Q4 '17: -0.70 Q1 '18: -0.96 Q2 '18: -0.85 Q3 '18: -0.38 Q4 '18: -4.24 Q1 '19: -3.89 Q2 '19: -3.51 Q3 '19: -3.61 Q4 '19: -3.17 Q1 '20: -3.09 Q2 '20: -3.38 Q3 '20: -3.13 Q4 '20: -2.49 Q1 '21: -2.48 Q2 '21: -2.20 Q3 '21: -2.40 Q4 '21: -3.37 Q1 '22: -3.55 Q2 '22: -3.56 Q3 '22: -3.10 Q4 '22: -1.95 Q1 '23: -1.48 Q2 '23: 0.11 Q3 '23: 0.79 Q4 '23: -0.15 Q1 '24: -0.38 Q2 '24: -2.19 Q3 '24: -1.57 Q4 '24: -1.07 Q1 '25: -0.88 Q2 '25: -0.56 Q3 '25: -1.19 Q4 '25: -1.17 Q1 '26: -1.10 Q2 '26: -0.22 Q1 '13 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.